Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311533039> ?p ?o ?g. }
- W4311533039 endingPage "8543" @default.
- W4311533039 startingPage "8543" @default.
- W4311533039 abstract "The undesirable side effects of conventional chemotherapy are one of the major problems associated with cancer treatment. Recently, with the development of novel nanomaterials, tumor-targeted therapies have been invented in order to achieve more specific cancer treatment with reduced unfavorable side effects of chemotherapic agents on human cells. However, the clinical application of nanomedicines has some shortages, such as the reduced ability to cross biological barriers and undesirable side effects in normal cells. In this order, bioinspired materials are developed to minimize the related side effects due to their excellent biocompatibility and higher accumulation therapies. As bioinspired and biomimetic materials are mainly composed of a nanometric functional agent and a biologic component, they can possess both the physicochemical properties of nanomaterials and the advantages of biologic agents, such as prolonged circulation time, enhanced biocompatibility, immune modulation, and specific targeting for cancerous cells. Among the nanomaterials, asymmetric nanomaterials have gained attention as they provide a larger surface area with more active functional sites compared to symmetric nanomaterials. Additionally, the asymmetric nanomaterials are able to function as two or more distinct components due to their asymmetric structure. The mentioned properties result in unique physiochemical properties of asymmetric nanomaterials, which makes them desirable materials for anti-cancer drug delivery systems or cancer bio-imaging systems. In this review, we discuss the use of bioinspired and biomimetic materials in the treatment of cancer, with a special focus on asymmetric nanoparticle anti-cancer agents." @default.
- W4311533039 created "2022-12-26" @default.
- W4311533039 creator A5025908059 @default.
- W4311533039 creator A5032308075 @default.
- W4311533039 creator A5032426241 @default.
- W4311533039 creator A5049503723 @default.
- W4311533039 creator A5053819107 @default.
- W4311533039 creator A5055525972 @default.
- W4311533039 creator A5059399366 @default.
- W4311533039 creator A5089680230 @default.
- W4311533039 date "2022-12-04" @default.
- W4311533039 modified "2023-10-03" @default.
- W4311533039 title "Synergistically Enhancing the Therapeutic Effect on Cancer, via Asymmetric Bioinspired Materials" @default.
- W4311533039 cites W1680239125 @default.
- W4311533039 cites W1882449741 @default.
- W4311533039 cites W1965927511 @default.
- W4311533039 cites W1968212891 @default.
- W4311533039 cites W1970442695 @default.
- W4311533039 cites W1976904757 @default.
- W4311533039 cites W1977918126 @default.
- W4311533039 cites W2010063286 @default.
- W4311533039 cites W2013875806 @default.
- W4311533039 cites W2050872914 @default.
- W4311533039 cites W2053396566 @default.
- W4311533039 cites W2062537354 @default.
- W4311533039 cites W2064996292 @default.
- W4311533039 cites W2066393834 @default.
- W4311533039 cites W2069210747 @default.
- W4311533039 cites W2073253894 @default.
- W4311533039 cites W2084065229 @default.
- W4311533039 cites W2091211957 @default.
- W4311533039 cites W2132677476 @default.
- W4311533039 cites W2164471294 @default.
- W4311533039 cites W2171792381 @default.
- W4311533039 cites W2226768541 @default.
- W4311533039 cites W2253627809 @default.
- W4311533039 cites W2284504324 @default.
- W4311533039 cites W2284805588 @default.
- W4311533039 cites W2288827496 @default.
- W4311533039 cites W2306700834 @default.
- W4311533039 cites W2312811933 @default.
- W4311533039 cites W2322209989 @default.
- W4311533039 cites W2328082795 @default.
- W4311533039 cites W2342952257 @default.
- W4311533039 cites W2406332780 @default.
- W4311533039 cites W2417603973 @default.
- W4311533039 cites W2522801262 @default.
- W4311533039 cites W2554773181 @default.
- W4311533039 cites W2557618066 @default.
- W4311533039 cites W2589560831 @default.
- W4311533039 cites W2595378874 @default.
- W4311533039 cites W2620948218 @default.
- W4311533039 cites W2624579886 @default.
- W4311533039 cites W2627388912 @default.
- W4311533039 cites W2740543737 @default.
- W4311533039 cites W2746893638 @default.
- W4311533039 cites W2746988592 @default.
- W4311533039 cites W2750857821 @default.
- W4311533039 cites W2754708902 @default.
- W4311533039 cites W2765464294 @default.
- W4311533039 cites W2766198919 @default.
- W4311533039 cites W2767801897 @default.
- W4311533039 cites W2768662807 @default.
- W4311533039 cites W2780719111 @default.
- W4311533039 cites W2786378926 @default.
- W4311533039 cites W2792608225 @default.
- W4311533039 cites W2795462196 @default.
- W4311533039 cites W2802688202 @default.
- W4311533039 cites W2834766065 @default.
- W4311533039 cites W2884443216 @default.
- W4311533039 cites W2887481910 @default.
- W4311533039 cites W2888989422 @default.
- W4311533039 cites W2890360615 @default.
- W4311533039 cites W2890975656 @default.
- W4311533039 cites W2901385649 @default.
- W4311533039 cites W2911675515 @default.
- W4311533039 cites W2914493074 @default.
- W4311533039 cites W2916607653 @default.
- W4311533039 cites W2947652429 @default.
- W4311533039 cites W2950461941 @default.
- W4311533039 cites W2963183577 @default.
- W4311533039 cites W2967502700 @default.
- W4311533039 cites W2971732306 @default.
- W4311533039 cites W2972884644 @default.
- W4311533039 cites W2975165308 @default.
- W4311533039 cites W2977907089 @default.
- W4311533039 cites W2977924735 @default.
- W4311533039 cites W2979459162 @default.
- W4311533039 cites W2981807138 @default.
- W4311533039 cites W2991966379 @default.
- W4311533039 cites W2994618781 @default.
- W4311533039 cites W2995040500 @default.
- W4311533039 cites W2999106070 @default.
- W4311533039 cites W3010536720 @default.
- W4311533039 cites W3010630785 @default.
- W4311533039 cites W3011568460 @default.
- W4311533039 cites W3014746372 @default.
- W4311533039 cites W3034140178 @default.